KRAS and neoplasm: Xu et al. demonstrated that in tumor cells activated by the tyrosine kinase receptor or KRAS oncogene, AKT phosphorylates PCK1 at serine 90, leading to the ER translocation of PCK1 and its protein kinase function [28].